Literature DB >> 29732182

Drugs pharmacokinetics during veno-venous extracorporeal membrane oxygenation in pediatrics.

Matteo Di Nardo1, Enno Diederick Wildschut2.   

Abstract

Data evaluating pharmacokinetic/pharmacodynamic (PK/PD) aspect in the pediatric population are scarce especially regarding the pediatric intensive care unit. Dosing of frequently used drugs (sedatives, analgesics, antibiotics and cardiovascular drugs) are mainly based on non "pediatric intensive care unit (PICU)" patients, and sometimes are translated from adult patients. Among PICU patients, the most complex patients are the ones who are critically ill and are receiving mechanical circulatory/respiratory support for cardiac and/or respiratory failure. The use of extracorporeal membrane oxygenation is associated with major PK and PD changes, especially in neonates and children. The objective of this review is to assess the current literature for pediatric PK data in patients receiving extracorporeal membrane oxygenation (ECMO).

Entities:  

Keywords:  Pediatric; extracorporeal membrane oxygenation (ECMO); pharmacodynamics (PD); pharmacokinetics (PKs)

Year:  2018        PMID: 29732182      PMCID: PMC5911549          DOI: 10.21037/jtd.2017.11.02

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  83 in total

1.  Pharmacokinetics of cefotaxime and desacetylcefotaxime in infants during extracorporeal membrane oxygenation.

Authors:  Maurice J Ahsman; Enno D Wildschut; Dick Tibboel; Ron A Mathot
Journal:  Antimicrob Agents Chemother       Date:  2010-02-22       Impact factor: 5.191

2.  Changes in the pharmacodynamic response to fentanyl in neonates during continuous infusion.

Authors:  J H Arnold; R D Truog; J M Scavone; T Fenton
Journal:  J Pediatr       Date:  1991-10       Impact factor: 4.406

3.  Pharmacokinetics of continuous-infusion meropenem in a pediatric patient receiving extracorporeal life support.

Authors:  Jeffrey J Cies; Wayne S Moore; Mindy J Dickerman; Christine Small; Dominick Carella; Arun Chopra; Jason Parker
Journal:  Pharmacotherapy       Date:  2014-08-22       Impact factor: 4.705

4.  Analytic reviews: propofol infusion syndrome in the ICU.

Authors:  Daniel A Diedrich; Daniel R Brown
Journal:  J Intensive Care Med       Date:  2011 Mar-Apr       Impact factor: 3.510

Review 5.  Bloodstream infections in pediatric ECLS: usefulness of daily blood culture monitoring and predictive value of biological markers. The British Columbia experience.

Authors:  Gregor W Kaczala; Stephane C Paulus; Nawaf Al-Dajani; Wilson Jang; Edith Blondel-Hill; Simon Dobson; Arthur Cogswell; Avash J Singh
Journal:  Pediatr Surg Int       Date:  2009-01-16       Impact factor: 1.827

6.  Plasma concentrations of oseltamivir and oseltamivir carboxylate in critically ill children on extracorporeal membrane oxygenation support.

Authors:  Enno D Wildschut; Matthijs de Hoog; Maurice J Ahsman; Dick Tibboel; Albert D M E Osterhaus; Pieter L A Fraaij
Journal:  PLoS One       Date:  2010-06-03       Impact factor: 3.240

7.  Effects of extracorporeal membrane oxygenation on morphine pharmacokinetics in infants.

Authors:  O Dagan; J Klein; D Bohn; G Koren
Journal:  Crit Care Med       Date:  1994-07       Impact factor: 7.598

8.  Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome.

Authors:  Andrew Davies; Daryl Jones; Michael Bailey; John Beca; Rinaldo Bellomo; Nikki Blackwell; Paul Forrest; David Gattas; Emily Granger; Robert Herkes; Andrew Jackson; Shay McGuinness; Priya Nair; Vincent Pellegrino; Ville Pettilä; Brian Plunkett; Roger Pye; Paul Torzillo; Steve Webb; Michael Wilson; Marc Ziegenfuss
Journal:  JAMA       Date:  2009-10-12       Impact factor: 56.272

9.  Opioid withdrawal in neonates after continuous infusions of morphine or fentanyl during extracorporeal membrane oxygenation.

Authors:  L S Franck; J Vilardi; D Durand; R Powers
Journal:  Am J Crit Care       Date:  1998-09       Impact factor: 2.228

10.  Propofol, midazolam, vancomycin and cyclosporine therapeutic drug monitoring in extracorporeal membrane oxygenation circuits primed with whole human blood.

Authors:  Florian Lemaitre; Nesrine Hasni; Pascal Leprince; Emmanuel Corvol; Ghassen Belhabib; Pierre Fillâtre; Charles-Edouard Luyt; Cyril Leven; Robert Farinotti; Christine Fernandez; Alain Combes
Journal:  Crit Care       Date:  2015-02-12       Impact factor: 9.097

View more
  4 in total

1.  Reply to Béranger et al., "Integration of Continuous Renal Replacement Therapy in a Meropenem Population Pharmacokinetics Model in Critically Ill Children".

Authors:  Jumpei Saito; Kensuke Shoji; Yusuke Oho; Hiroki Kato; Shotaro Matsumoto; Satoshi Aoki; Hidefumi Nakamura; Takanori Ogawa; Mayumi Hasegawa; Akimasa Yamatani; Isao Miyairi
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

2.  Impaired Pharmacokinetics of Amiodarone under Veno-Venous Extracorporeal Membrane Oxygenation: From Bench to Bedside.

Authors:  Mickaël Lescroart; Claire Pressiat; Benjamin Péquignot; N'Guyen Tran; Jean-Louis Hébert; Nassib Alsagheer; Nicolas Gambier; Bijan Ghaleh; Julien Scala-Bertola; Bruno Levy
Journal:  Pharmaceutics       Date:  2022-04-30       Impact factor: 6.525

Review 3.  Therapeutic Drug Monitoring Is a Feasible Tool to Personalize Drug Administration in Neonates Using New Techniques: An Overview on the Pharmacokinetics and Pharmacodynamics in Neonatal Age.

Authors:  Domenico Umberto De Rose; Sara Cairoli; Marco Dionisi; Alessandra Santisi; Luca Massenzi; Bianca Maria Goffredo; Carlo Dionisi-Vici; Andrea Dotta; Cinzia Auriti
Journal:  Int J Mol Sci       Date:  2020-08-17       Impact factor: 5.923

Review 4.  Pediatric Drug-Drug Interaction Evaluation: Drug, Patient Population, and Methodological Considerations.

Authors:  Daniel Gonzalez; Jaydeep Sinha
Journal:  J Clin Pharmacol       Date:  2021-06       Impact factor: 2.860

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.